A Review of the Most Influential Research Papers On Covid-19: An Excerpt With Comments and Insights

Sudipta Sinha; Modak Nikunja Mohan; Sana Shib Sankar

doi:10.2298/YJOR231215006S

Authors

Sudipta Sinha Department of Mathematics, Burdwan Raj College, University of Burdwan, West Bengal, India https://orcid.org/0000-0001-7460-813X
Modak Nikunja Mohan Palpara Vidyamandir, Chakdaha, Nadia, West Bengal, India https://orcid.org/0000-0001-7646-5750
Sana Shib Sankar Kishore Bharati Bhagini Nivedita College(Co-Ed), Behala, Kolkata, India https://orcid.org/0000-0002-7834-8969

DOI:

https://doi.org/10.2298/YJOR231215006S

Keywords:

Review, Covid-19, influential publications, human, pandemic, clinical trials

Abstract

For the past two years, COVID-19 has been a global nightmare for human civilization. It genuinely poses a serious threat to public health because of its rapid proliferation. The deadly SARS-COV-2 virus is being researched on a global scale to determine its biology, origin, and potential treatment. Numerous research publications covering various aspects of the COVID-19 issue have already been published as a result of the burgeoning interest in this hot topic. The reputable and well-known search engine SCOPUS is used to compile crucial information. In order to emphasize a thorough and extensive assessment of research output using COVID-19 publications, we looked at 100 research and review papers that received the majority of citations. It discovers a list of keywords that appear more than 14 times. It can be seen that the terms "Human/ Humans," "Coronavirus Disease 2019," "Coronavirus Infection/Coronavirus Infections," "Pneumonia viral," and "Virus pneumonia" held the top five positions. The New England Journal of Medicine is in the first place, having published 15 research papers delineating different features of SARS-CoV-2. In addition to this, a significant number of publications connected to the Covid-19 issue were also published in "The Lancet," "Nature," "JAMA Journal of the American Medical Association," and "Cell." Regarding papers published on COVID-19, China is also performing well. The USA and the UK placed second and third, respectively, in terms of the quantity of Covid-related articles published. This work outlines a detailed global research scenario of COVID-19 describing its origin, nature, identification, way of entry in a human cell, symptoms of the infected patients, way of prevention, fatal effects on comorbid and aged patients with the help of correlation between comorbidity and mortality, the effect of on newborn baby and children, the emergence of telemedicine, persistence of the virus on inanimate things, the efficacy of drugs like remdesivir, lopinavir, ritonavir and so on, the progress of vaccine development, usefulness gloves, masks, sanitizer, the advantage of maintaining physical and social distance, infrastructure development. Finally, we conclude by summarizing the main points of the 100 research papers, which will undoubtedly aid in identifying the research gap and future research directions.

References

M. Ackermann, Verleden, S. E., Kuehnel, M., Haverich, A., Welte, T., Laenger, F., Jonigk, D. “Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in covid-19”, New England Journal of Medicine, vol. 383, no. 2, pp. 120-128, 2020. doi:10.1056/NEJMoa2015432

T. Ai, Yang, Z., Hou, H., Zhan, C., Chen, C., Lv, W., Xia, L. “Correlation of chest CT and RT-PCR testing for coronavirus disease 2019 (COVID-19) in China: A report of 1014 cases”. Radiology, vol. 296, no. 2, pp. E32-E40, 2020. doi:10.1148/radiol.2020200642

L. R. Baden, El Sahly, H. M., Essink, B., Kotloff, K., Frey, S., Novak, R., Zaks, T. “Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine”. New England Journal of Medicine, vol. 384, no. 5, pp. 403-416, 2021. doi:10.1056/NEJMoa2035389

J. J. V. Bavel, K. Baicker, P. S. Boggio, V. Capraro, A. Cichocka, M. Cikara, and R. Willer, “Using social and behavioural science to support COVID-19 pandemic response,”Nature Human Behaviour, vol. 4, no. 5, pp. 460-471, 2020. doi:10.1038/s41562-020-0884-z.

J. H. Beigel, K. M. Tomashek, L. E. Dodd, A. K. Mehta, B. S. Zingman, A. C. Kalil, and H. C. Lane, “Remdesivir for the treatment of COVID-19 - final report,” New England Journal of Medicine, vol. 383, no. 19, pp. 1813-1826, 2020. doi:10.1056/NEJMoa2007764.

A. Bernheim, X. Mei, M. Huang, Y. Yang, Z. A. Fayad, N. Zhang, and M. Chung,“Chest CT findings in coronavirus disease 2019 (COVID-19): Relationship to duration of infection,” Radiology, vol. 295, no. 3, pp. 685-691, 2020. doi:10.1148/radiol.2020200463.

P. K. Bhatraju, B. J. Ghassemieh, M. Nichols, R. Kim, K. R. Jerome, A. K. Nalla, and C. Mikacenic, “COVID-19 in critically ill patients in the Seattle region - case series,” New England Journal of Medicine, vol. 382, no. 21, pp. 2012-2022, 2020. doi:10.1056/NEJMoa2004500.

B. Bikdeli, M. V. Madhavan, D. Jimenez, T. Chuich, I. Dreyfus, E. Driggin, and G. Y. H. Lip, “COVID-19 and thrombotic or thromboembolic disease: Implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review,” Journal of the American College of Cardiology, vol. 75, no. 23, pp. 2950-2973, 2020. doi:10.1016/j.jacc.2020.04.031.

D. Blanco-Melo, B. E. Nilsson-Payant, W. Liu, S. Uhl, D. Hoagland, R. Møller, and B. R. tenOever, “Imbalanced host response to SARS-CoV-2 drives development of COVID-19,” Cell, vol. 181, no. 5, pp. 1036-1045.e9, 2020. doi:10.1016/j.cell.2020.04.026.

B. Cao, Y. Wang, D. Wen, W. Liu, J. Wang, G. Fan, and C. Wang, “A trial of lopinavir-ritonavir in adults hospitalized with severe COVID-19,” New England Journal of Medicine, vol. 382, no. 19, pp. 1787-1799, 2020. doi:10.1056/NEJMoa2001282.

W. Cao, Fang, Z., Hou, G., Han, M., Xu, X., Dong, J., & Zheng, J. “The psychological impact of the COVID-19 epidemic on college students in China,” Psychiatry Research, vol. 287, 2020. doi:10.1016/j.psychres.2020.112934.

J. F. Chan, K. K. Kok, Z. Zhu, H. Chu, K. K. W. To, S. Yuan, and K. Y. Yuen, “Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan,” Emerging Microbes and Infections, vol. 9, no. 1, pp. 221-236, 2020. doi:10.1080/22221751.2020.1719902.

J. F. W. Chan, S. Yuan, K. K. Kok, K. K. W. To, H. Chu, J. Yang, and K. Y. Yuen, “A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: A study of a family cluster,” The Lancet, vol. 395, no. 10223, pp. 514-523, 2020. doi:10.1016/S0140-6736(20)30154-9.

G. Chen, Wu, D., Guo, W., Cao, Y., Huang, D., Wang, H., Ning, Q. “Clinical and immunological features of severe and moderate coronavirus disease 2019,” Journal of Clinical Investigation, vol. 130, no. 5, pp. 2620-2629, 2020. doi:10.1172/JCI137244.

H. Chen, Guo, J., Wang, C., Luo, F., Yu, X., Zhang, W., Zhang, Y. “Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: A retrospective review of medical records,” The Lancet, vol. 395, no. 10226, pp. 809-815, 2020. doi:10.1016/S0140-6736(20)30360-3.

N. Chen, Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Zhang, L. “Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study,” The Lancet, vol. 395, no. 10223, pp. 507-513, 2020. doi:10.1016/S0140-6736(20)30211-7.

T. Chen, D. Wu, H. Chen, W. Yan, D. Yang, G. Chen, and Q. Ning, “Clinical characteristics of 113 deceased patients with coronavirus disease 2019: Retrospective study,” The BMJ, vol. 368, 2020. doi:10.1136/bmj.m1091.

Y. Chen, Q. Liu, and D. Guo, “Emerging coronaviruses: Genome structure, replication, and pathogenesis,” Journal of Medical Virology, vol. 92, no. 4, pp. 418-423, 2020. doi:10.1002/jmv.25681.

M. Chinazzi, J. T. Davis, M. Ajelli, C. Gioannini, M. Litvinova, S. Merler, and A. Vespignani, “The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak,” Science, vol. 368, no. 6489, pp. 395-400, 2020. doi:10.1126/science.aba9757.

D. K. Chu, E. A. Akl, S. Duda, K. Solo, S. Yaacoub, H. J. Schünemann, and M. Reinap, “Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: A systematic review and meta-analysis,” The Lancet, vol. 395, no. 10242, pp. 1973-1987, 2020. doi:10.1016/S0140-6736(20)31142-9.

M. Chung, A. Bernheim, X. Mei, N. Zhang, M. Huang, X. Zeng, and H. Shan, “CT imaging features of 2019 novel coronavirus (2019-NCoV),” Radiology, vol. 295, no. 1, pp. 202-207, 2020. doi:10.1148/radiol.2020200230.

A. B. Docherty, E. M. Harrison, C. A. Green, H. E. Hardwick, R. Pius, L. Norman, and M. G. Semple, “Features of 20,133 UK patients in hospital with COVID-19 using the ISARIC WHO clinical characterization protocol: Prospective observational cohort study,” The BMJ, vol. 369, 2020. doi:10.1136/bmj.m1985.

Y. Dong, Y. Dong, X. Mo, Y. Hu, X. Qi, F. Jiang, and S. Tong, “Epidemiology of COVID-19 among children in China,” Pediatrics, vol. 145, no. 6, 2020. doi:10.1542/peds.2020-0702.

E. J. Emanuel, G. Persad, R. Upshur, B. Thome, M. Parker, A. Glickman, and J. P. Phillips, “Fair allocation of scarce medical resources in the time of covid-19,” New England Journal of Medicine, vol. 382, no. 21, pp. 2049-2055, 2020. doi:10.1056/NEJMsb2005114.

P. Gautret, J. Lagier, P. Parola, V. T. Hoang, L. Meddeb, M. Mailhe, and D. Raoult, “Hydroxychloroquine and azithromycin as a treatment of COVID-19: Results of an open-label non-randomized clinical trial,” International Journal of Antimicrobial Agents, vol. 56, no. 1, 2020. doi:10.1016/j.ijantimicag.2020.105949.

D. E. Gordon, G. M. Jang, M. Bouhaddou, J. Xu, K. Obernier, K. M. White, and N. J. Krogan, “A SARS-CoV-2 protein interaction map reveals targets for drug repurposing,” Nature, vol. 583, no. 7816, pp. 459-468, 2020. doi:10.1038/s41586-020-2286-9.

N. Goyal, M. Chung, A. Bernheim, and P. Kenne, “Computed Tomography Features of Coronavirus Disease 2019 (COVID-19): A Review for Radiologists,” Journal of Thoracic Imaging, vol. 35, no. 4, pp. 211-218, 2020. doi:10.1097/RTI.0000000000000527.

G. Grasselli, A. Zangrillo, A. Zanella, M. Antonelli, L. Cabrini, A. Castelli, and A. Pesenti, “Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy,” JAMA - Journal of the American Medical Association, vol. 323, no. 16, pp. 1574-1581, 2020. doi:10.1001/jama.2020.5394.

J. Grein, N. Ohmagari, D. Shin, G. Diaz, E. Asperges, A. Castagna, and T. Flanigan, “Compassionate use of remdesivir for patients with severe covid-19,” New England Journal of Medicine, vol. 382, no. 24, pp. 2327-2336, 2020. doi:10.1056/NEJMoa2007016.

A. Grifoni, D. Weiskopf, S. I. Ramirez, J. Mateus, J. M. Dan, C. R. Moderbacher, and A. Sette, “Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals,” Cell, vol. 181, no. 7, pp. 1489-1501.e15, 2020. doi:10.1016/j.cell.2020.05.015.

W. Guan, Z. Ni, Y. Hu, W. Liang, C. Ou, J. He, and N. Zhong, “Clinical characteristics of coronavirus disease 2019 in China,” New England Journal of Medicine, vol. 382, no. 18, pp. 1708-1720, 2020. doi:10.1056/NEJMoa2002032.

W. Guan, W. Liang, Y. Zhao, H. Liang, Z. Chen, Y. Li, and J. He, “Comorbidity and its impact on 1,590 patients with covid-19 in China: A nationwide analysis,” European Respiratory Journal, vol. 55, no. 5, 2020. doi:10.1183/13993003.00547-2020.

T. Guo, Fan, Y., Chen, M., Wu, X., Zhang, L., He, T., and Lu, Z., “Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19),” JAMA Cardiology, vol. 5, no. 7, pp. 811-818, 2020. doi:10.1001/jamacardio.2020.1017

Y. R. Guo, Cao, Q., Hong, Z., Tan, Y., Chen, S., Jin, H., and Yan, Y., “The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - An update on the status,” Military Medical Research, vol. 7, no. 1, 2020. doi:10.1186/s40779-020-00240-0

X. He, Lau, E. H. Y., Wu, P., Deng, X., Wang, J., Hao, X., and Leung, G. M., “Temporal dynamics in viral shedding and transmissibility of COVID-19,” Nature Medicine, vol. 26, no. 5, pp. 672-675, 2020. doi:10.1038/s41591-020-0869-5

J. Hellewell, Abbott, S., Gimma, A., Bosse, N. I., Jarvis, C. I., Russell, T. W., and Eggo, R. M., “Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts,” The Lancet Global Health, vol. 8, no. 4, pp. e488-e496, 2020. doi:10.1016/S2214-109X(20)30074-7

J. Helms, Tacquard, C., Severac, F., Leonard-Lorant, I., Ohana, M., Delabranche, X., and Meziani, F., “High risk of thrombosis in patients with severe SARS-CoV-2 infection: A multicenter prospective cohort study,” Intensive Care Medicine, vol. 46, no. 6, pp. 1089-1098, 2020. doi:10.1007/s00134-020-06062-x

M. Hoffmann, Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., and Pöhlmann, S., “SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor,” Cell, vol. 181, no. 2, pp. 271-280.e8, 2020. doi:10.1016/j.cell.2020.02.052

J. E. Hollander and B. G. Carr, “Virtually perfect? Telemedicine for COVID-19,” New England Journal of Medicine, vol. 382, no. 18, pp. 1679-1681, 2020. doi:10.1056/NEJMp2003539

E. A. Holmes, O'Connor, R. C., Perry, V. H., Tracey, I., Wessely, S., Arseneault, L., and Bullmore, E., “Multidisciplinary research priorities for the COVID-19 pandemic: A call for action for mental health science,” The Lancet Psychiatry, vol. 7, no. 6, pp. 547-560, 2020. doi:10.1016/S2215-0366(20)30168-1

M. L. Holshue, C. DeBolt, S. Lindquist, K. H. Lofy, J. Wiesman, H. Bruce, and S. K. Pillai, “First case of 2019 novel coronavirus in the United States,” New England Journal of Medicine, vol. 382, no. 10, pp. 929-936, 2020. doi:10.1056/NEJMoa2001191

P. Horby, W. S. Lim, J. R. Emberson, M. Mafham, J. L. Bell, L. Linsell, and M. J. Landray, “Dexamethasone in hospitalized patients with covid-19,” New England Journal of Medicine, vol. 384, no. 8, pp. 693-704, 2021. doi:10.1056/NEJMoa2021436

C. Huang, Y. Wang, X. Li, L. Ren, J. Zhao, Y. Hu, and B. Cao, “Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China,” The Lancet, vol. 395, no. 10223, pp. 497-506, 2020. doi:10.1016/S0140-6736(20)30183-5

Z. Jin, X. Du, Y. Xu, Y. Deng, M. Liu, Y. Zhao, and H. Yang, “Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors,” Nature, vol. 582, no. 7811, pp. 289-293, 2020. doi:10.1038/s41586-020-2223-y

G. Kampf, D. Todt, S. Pfaender, and E. Steinmann, “Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents,” Journal of Hospital Infection, vol. 104, no. 3, pp. 246-251, 2020. doi:10.1016/j.jhin.2020.01.022

F. A. Klok, M. J. H. A. Kruip, N. J. M. van der Meer, M. S. Arbous, D. A. M. P. J. Gommers, K. M. Kant, and H. Endeman, “Incidence of thrombotic complications in critically ill ICU patients with COVID-19,” Thrombosis Research, vol. 191, pp. 145-147, 2020. doi:10.1016/j.thromres.2020.04.013

B. Korber, W. M. Fischer, S. Gnanakaran, H. Yoon, J. Theiler, W. Abfalterer, and D. C. Montefiori, “Tracking changes in SARS-CoV-2 spike: Evidence that D614G increases infectivity of the COVID-19 virus,” Cell, vol. 182, no. 4, pp. 812-827.e19, 2020. doi:10.1016/j.cell.2020.06.043

C. C. Lai, T. Shih, W. Ko, H. Tang, and P. Hsueh, “Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges,” International Journal of Antimicrobial Agents, vol. 55, no. 3, 2020. doi:10.1016/j.ijantimicag.2020.105924

J. Lai, S. Ma, Y. Wang, Z. Cai, J. Hu, N. Wei, and S. Hu, “Factors associated with mental health outcomes among health care workers exposed to coronavirus disease 2019,” JAMA Network Open, vol. 3, no. 3, 2020. doi:10.1001/jamanetworkopen.2020.3976

S. A. Lauer, K. H. Grantz, Q. Bi, F. K. Jones, Q. Zheng, H. R. Meredith, and J. Lessler, “The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: Estimation and application,” Annals of Internal Medicine, vol. 172, no. 9, pp. 577-582, 2020. doi:10.7326/M20-0504

J. R. Lechien, C. M. Chiesa-Estomba, D. R. De Siati, M. Horoi, S. D. Le Bon, A. Rodriguez, and S. Saussez, “Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): A multicenter European study,” European Archives of Oto-Rhino-Laryngology, vol. 277, no. 8, pp. 2251-2261, 2020. doi:10.1007/s00405-020-059651

M. Letko, A. Marzi, and V. Munster, “Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B beta coronaviruses,” Nature Microbiology, vol. 5, no. 4, pp. 562-569, 2020. doi:10.1038/s41564-020-0688-y

Y. Li, W. Bai, and T. Hashikawa, “The neuroinvasive potential of SARS-CoV-2 may play a role in the respiratory failure of COVID-19 patients,” Journal of Medical Virology, vol. 92, no. 6, pp. 552-555, 2020. doi:10.1002/jmv.25728

Y. Liu, A. A. Gayle, A. Wilder-Smith, and J. Rocklöv, “The reproductive number of COVID-19 is higher compared to SARS coronavirus,” Journal of Travel Medicine, vol. 27, no. 2, 2020. doi:10.1093/jtm/taaa021

Q. Long, B. Liu, H. Deng, G. Wu, K. Deng, Y. Chen, and A. Huang, “Antibody responses to SARS-CoV-2 in patients with COVID-19,” Nature Medicine, vol. 26, no. 6, pp. 845-848, 2020. doi:10.1038/s41591-020-0897-1

R. Lu, X. Zhao, J. Li, P. Niu, B. Yang, H. Wu, and W. Tan, “Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding,” The Lancet, vol. 395, no. 10224, pp. 565-574, 2020. doi:10.1016/S0140-6736(20)30251-8

L. Mao, H. Jin, M. Wang, Y. Hu, S. Chen, Q. He, and B. Hu, “Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China,” JAMA Neurology, vol. 77, no. 6, pp. 683-690, 2020. doi:10.1001/jamaneurol.2020.1127

K. Mizumoto, K. Kagaya, A. Zarebski, and G. Chowell, “Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020,” Eurosurveillance, vol. 25, no. 10, 2020. doi:10.2807/1560-7917.ES.2020.25.10.2000180

M. Nicola, Z. Alsafi, C. Sohrabi, A. Kerwan, A. Al-Jabir, C. Iosifidis, and R. Agha, “The socio-economic implications of the coronavirus pandemic (COVID-19): A review,” International Journal of Surgery, vol. 78, pp. 185-193, 2020. doi:10.1016/j.ijsu.2020.04.018

X. Ou, Y. Liu, X. Lei, P. Li, D. Mi, L. Ren, and Z. Qian, “Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV,” Nature Communications, vol. 11, no. 1, 2020. doi:10.1038/s41467-020-15562-9

F. Pan, T. Ye, P. Sun, S. Gui, B. Liang, L. Li, and C. Zheng, “Time course of lung changes at chest CT during recovery from coronavirus disease 2019 (COVID-19),” Radiology, vol. 295, no. 3, pp. 715-721, 2020. doi:10.1148/radiol.2020200370

B. Pfefferbaum and C. S. North, “Mental health and the COVID-19 pandemic,” The New England Journal of Medicine, vol. 383, no. 6, pp. 510-512, 2020. doi:10.1056/NEJMp2008017

F. P. Polack, S. J. Thomas, N. Kitchin, J. Absalon, A. Gurtman, S. Lockhart, and W. C. Gruber, “Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine,” New England Journal of Medicine, vol. 383, no. 27, pp. 2603-2615, 2020. doi:10.1056/NEJMoa2034577

C. Qin, L. Zhou, Z. Hu, S. Zhang, S. Yang, Y. Tao, and D. Tian, “Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China,” Clinical Infectious Diseases, vol. 71, no. 15, pp. 762-768, 2020. doi:10.1093/cid/ciaa248

J. Qiu, B. Shen, M. Zhao, Z. Wang, B. Xie, and Y. Xu, “A nationwide survey of psychological distress among Chinese people in the COVID-19 epidemic: Implications and policy recommendations,” General Psychiatry, vol. 33, no. 2, 2020. doi:10.1136/gpsych-2020-100213

R. P. Rajkumar, “COVID-19 and mental health: A review of the existing literature,” Asian Journal of Psychiatry, vol. 52, 2020. doi:10.1016/j.ajp.2020.102066

A. Remuzzi and G. Remuzzi, “COVID-19 and Italy: What next?,” The Lancet, vol. 395, no. 10231, pp. 1225-1228, 2020. doi:10.1016/S0140-6736(20)30627-9

S. Richardson, J. S. Hirsch, M. Narasimhan, J. M. Crawford, T. McGinn, K. W. Davidson, and T. P. Zanos, “Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area,” JAMA, vol. 323, no. 20, pp. 2052-2059, 2020. doi:10.1001/jama.2020.6775

H. A. Rothan and S. N. Byrareddy, “The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak,” Journal of Autoimmunity, vol. 109, 2020. doi:10.1016/j.jaut.2020.102433

J. M. Sanders, M. L. Monogue, T. Z. Jodlowski, and J. B. Cutrell, “Pharmacologic treatments for coronavirus disease 2019 (COVID-19): A review,” JAMA, vol. 323, no. 18, pp. 1824-1836, 2020. doi:10.1001/jama.2020.6019

C. Shen, Z. Wang, F. Zhao, Y. Yang, J. Li, J. Yuan, and L. Liu, “Treatment of 5 critically ill patients with COVID-19 with convalescent plasma,” JAMA, vol. 323, no. 16, pp. 1582-1589, 2020. doi:10.1001/jama.2020.4783

M. A. Shereen, S. Khan, A. Kazmi, N. Bashir, and R. Siddique, “COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses,” Journal of Advanced Research, vol. 24, pp. 91-98, 2020. doi:10.1016/j.jare.2020.03.005

H. Shi, X. Han, N. Jiang, Y. Cao, O. Alwalid, J. Gu, and C. Zheng, “Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: A descriptive study,” The Lancet Infectious Diseases, vol. 20, no. 4, pp. 425-434, 2020. doi:10.1016/S1473-3099(20)30086-4

S. Shi, M. Qin, B. Shen, Y. Cai, T. Liu, F. Yang, and C. Huang, “Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China,” JAMA Cardiology, vol. 5, no. 7, pp. 802-810, 2020. doi:10.1001/jamacardio.2020.0950

T. Singhal, “A review of coronavirus disease-2019 (COVID-19),” Indian Journal of Pediatrics, vol. 87, no. 4, pp. 281-286, 2020. doi:10.1007/s12098-020-03263-6

C. Sohrabi, Z. Alsafi, N. O'Neill, M. Khan, A. Kerwan, A. Al-Jabir, and R. Agha, “World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19),” International Journal of Surgery, vol. 76, pp. 71-76, 2020. doi:10.1016/j.ijsu.2020.02.034

N. Tang, H. Bai, X. Chen, J. Gong, D. Li, and Z. Sun, “Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy,” Journal of Thrombosis and Haemostasis, vol. 18, no. 5, pp. 1094-1099, 2020. doi:10.1111/jth.14817

M. Z. Tay, C. M. Poh, L. Rénia, P. A. MacAry, and L. F. P. Ng, “The trinity of COVID-19: Immunity, inflammation and intervention,” Nature Reviews Immunology, vol. 20, no. 6, pp. 363-374, 2020. doi:10.1038/s41577-020-0311-8

K. K. To, O. T. Y. Tsang, W. S. Leung, A. R. Tam, T. Y. Wu, D. C. Lung, and K. Y. Yuen, “Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: An observational cohort study,” The Lancet Infectious Diseases, vol. 20, no. 5, pp. 565-574, 2020. doi:10.1016/S1473-3099(20)30196-1

M. Vaduganathan, O. Vardeny, T. Michel, J. J. V. McMurray, M. A. Pfeffer, and S. D. Solomon, “Renin-angiotensin-aldosterone system inhibitors in patients with COVID-19,” New England Journal of Medicine, vol. 382, no. 17, pp. 1653-1659, 2020. doi:10.1056/NEJMsr2005760

R. Verity, L. C. Okell, I. Dorigatti, P. Winskill, C. Whittaker, N. Imai, and N. M. Ferguson, “Estimates of the severity of coronavirus disease 2019: A model-based analysis,” The Lancet Infectious Diseases, vol. 20, no. 6, pp. 669-677, 2020. doi:10.1016/S1473-3099(20)30243-7

Y. Wan, J. Shang, R. Graham, R. S. Baric, and F. Li, “Receptor recognition by the novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS coronavirus,” Journal of Virology, vol. 94, no. 7, 2020. doi:10.1128/JVI.00127-20

C. Wang, R. Pan, X. Wan, Y. Tan, L. Xu, C. S. Ho, and R. C. Ho, “Immediate psychological responses and associated factors during the initial stage of the 2019 coronavirus disease (COVID-19) epidemic among the general population in China,” International Journal of Environmental Research and Public Health, vol. 17, no. 5, 2020. doi:10.3390/ijerph17051729

Y. Wang, D. Zhang, G. Du, R. Du, J. Zhao, Y. Jin, and C. Wang, “Remdesivir in adults with severe COVID-19: A randomised, double-blind, placebo-controlled, multicentre trial,” The Lancet, vol. 395, no. 10236, pp. 1569-1578, 2020. doi:10.1016/S0140-6736(20)31022-9

W. J. Wiersinga, A. Rhodes, A. C. Cheng, S. J. Peacock, and H. C. Prescott, “Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): A review,” JAMA - Journal of the American Medical Association, vol. 324, no. 8, pp. 782-793, 2020. doi:10.1001/jama.2020.12839

E. J. Williamson, A. J. Walker, K. Bhaskaran, S. Bacon, C. Bates, C. E. Morton, and B. Goldacre, “Factors associated with COVID-19-related death using OpenSAFELY,” Nature, vol. 584, no. 7821, pp. 430-436, 2020. doi:10.1038/s41586-020-2521-4

R. Wölfel, V. M. Corman, W. Guggemos, M. Seilmaier, S. Zange, M. A. Müller, and C. Wendtner, “Virological assessment of hospitalized patients with COVID-2019,” Nature, vol. 581, no. 7809, pp. 465-469, 2020. doi:10.1038/s41586-020-2196-x

C. Wu, X. Chen, Y. Cai, J. Xia, X. Zhou, S. Xu, and Y. Song, “Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China,” JAMA Internal Medicine, vol. 180, no. 7, pp. 934-943, 2020. doi:10.1001/jamainternmed.2020.0994

F. Wu, S. Zhao, B. Yu, Y. Chen, W. Wang, Z. Song, and Y. Zhang, “A new coronavirus associated with human respiratory disease in China,” Nature, vol. 579, no. 7798, pp. 265-269, 2020. doi:10.1038/s41586-020-2008-3

H. Xu, Zhong, L., Deng, J., Peng, J., Dan, H., Zeng, X., Chen, Q. “High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa,” International Journal of Oral Science, vol. 12, no. 1, 2020. doi:10.1038/s41368-020-0074-x

X. Xu, M. Han, T. Li, W. Sun, D. Wang, B. Fu, and H. Wei, “A pneumonia outbreak associated with a new coronavirus of probable bat origin,” Proceedings of the National Academy of Sciences of the United States of America, vol. 117, no. 20, pp. 10970-10975, 2020. doi:10.1073/pnas.2005615117.

Z. Xu, L. Shi, Y. Wang, J. Zhang, L. Huang, C. Zhang, and F. Wang, “Pathological findings of COVID-19 associated with acute respiratory distress syndrome,” The Lancet Respiratory Medicine, vol. 8, no. 4, pp. 420-422, 2020. doi:10.1016/S2213-2600(20)30076-X.

R. Yan, Y. Zhang, Y. Li, L. Xia, Y. Guo, and Q. Zhou, “Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2,” Science, vol. 367, no. 6485, pp. 1444-1448, 2020. doi:10.1126/science.abb2762.

J. Yang, Y. Zheng, X. Gou, K. Pu, Z. Chen, Q. Guo, and Y. Zhou, “Prevalence of comorbidities and its effects in coronavirus disease 2019 patients: A systematic review and meta-analysis,” International Journal of Infectious Diseases, vol. 94, pp. 91-95, 2020. doi:10.1016/j.ijid.2020.03.017.

Q. Ye, B. Wang, and J. Mao, “The pathogenesis and treatment of the ‘Cytokine storm’ in COVID-19,” Journal of Infection, vol. 80, no. 6, pp. 607-613, 2020. doi:10.1016/j.jinf.2020.03.037

J. Zhang, X. Dong, Y. Cao, Y. Yuan, Y. Yang, Y. Yan, and Y. Gao, “Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China,” Allergy: European Journal of Allergy and Clinical Immunology, vol. 75, no. 7, pp. 1730-1741, 2020. doi:10.1111/all.14238.

L. Zhang, Lin, D., Sun, X., Curth, U., Drosten, C., Sauerhering, L., Hilgenfeld, R. “Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved a-ketoamide inhibitors”, Science, vol. 368, no. 6489, pp. 409-412, 2020. doi:10.1126/science.abb3405

J. Zhao, Yuan, Q., Wang, H., Liu, W., Liao, X., Su, Y., Zhang, Z. “Antibody responses to SARS-CoV-2 in patients with novel coronavirus disease 2019”, Clinical Infectious Diseases, vol. 71, no. 16, pp. 2027-2034, 2020. doi:10.1093/cid/ciaa344

F. Zhou, Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Cao, B. “Clinical course and risk factors for mortality of adult inpatients with COVID-19 in wuhan, china: A retrospective cohort study”, The Lancet, vol. 395, no. 10229, pp. 1054-1062, 2020. doi:10.1016/S0140-6736(20)30566-3

P. Zhou, X. Yang, X. Wang, B. Hu, L. Zhang, W. Zhang, and Z. Shi, “A pneumonia outbreak associated with a new coronavirus of probable bat origin,” Nature, vol. 579, no. 7798, pp. 270-273, 2020. doi:10.1038/s41586-020-2012-7.

N. Zhu, Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Tan, W. “A novel coronavirus from patients with pneumonia in china, 2019,” New England Journal of Medicine, vol. 382, no. 8, pp. 727-733, 2020. doi: 10.1056/NEJMoa2001017

A Review of the Most Influential Research Papers On Covid-19: An Excerpt With Comments and Insights

Authors

DOI:

Keywords:

Abstract

References

Downloads

Published

How to Cite

Issue

Section

License

Journal info

Journal Information

Scopus

scimago

indexing